Full Paper
Lys-ATP generated visible fluorescence under irradiation, con-
firming the attachment of the fluorescent fluor488 fragment.
Due to the lack of an alkyne moiety, the Fc-CO-C6-phospho-
peptide displayed only weak background fluorescence signals
as shown in entry 2.
without further purification. Goat anti-rabbit IgG (H+L) secondary
antibody, DyLight 488 conjugate was purchased from Thermo Sci-
entific, Canada.
Synthesis
Preparation of Fc-CO-Lys-Boc (2): Compound 1 (400 mg) was dis-
solved in MeOH/H O/THF (3 mL:3 mL:1 mL). Then LiOH (6 equiv)
2
was added to this solution. The reaction mixture was stirred in the
dark at RT for two days. Then THF was removed in vacuum and
water (15 mL) was added. The aqueous phase was washed with di-
chloromethane (3ꢁ10 mL) and then treated with 2m HCl till pH
ꢀ2 was reached. Dichloromethane (15 mL) was added to dissolve
the precipitate, which was further washed with brine (3ꢁ10 mL)
Conclusion
A new Fc-ATP compound containing a functional alkyne
moiety has been synthesized and characterized. A comparative
electrochemical study between this compound and related Fc-
CO-C6-ATP was carried out by using surface-bounded peptides
phosphorylated by Src, CDK2, and CK2a kinases. Obvious elec-
trochemical signals were detected, indicating the effectiveness
of Fc-CO-Lys-ATP as co-substrate in the reaction. These studies
also show that this compound can be applied to the Fc-Ab1/
and dried over MgSO . After solvent removal, the yellow solid (Fc-
4
CO-Lys(OH)-NHBoc) was used in the next step without further pu-
rification. EDC·HCl (1.38 mmol, 266 mg, 2.5 equiv) and HOBt
(
1.38 mmol, 213 mg, 2.5 equiv) were added to an anhydrous solu-
tion of Fc-CO-Lys(OH)-NHBoc (250 mg, 1 equiv) in dichloromethane
15 mL) on an ice bath. Then DIPEA (0.14 mL, 2.5 equiv) and prop-
(
Ab system, providing both electrochemical results and immu-
2
argylamine (1.1 mmol, 61 mg, 2 equiv) were added to this solution.
The reaction mixture was continuously stirred overnight under N2
atmosphere. After the reaction was completed, the solution was
nodetection. An azide-attached organic dye was successfully
linked to this Fc-CO-Lys-phosphate peptide film through click
chemistry. Thus, this compound has significant potential for
further application in the study of enzymatic post-translations
and we will evaluate the feasibility of “clickable” substrates to
replace the well-established immunoassay.
washed with saturated aqueous NaHCO solution (3ꢁ50 mL), 10%
3
critic acid (3ꢁ50 mL), and brine (3ꢁ50 mL). The organic layers
were dried over MgSO and the solvent was evaporated. The resi-
4
dues were purified by column with dichloromethane/MeOH (97:3)
1
to isolate the product as yellow solids (yield 75%). H NMR (DMSO,
2
98 K): d=8.32 (t, J=5.0 Hz, 1H), 7.68 (d, J=8.3 Hz, 1H), 6.78 (t,
J=5.5 Hz, 1H), 4.88 (s, 2H), 4.35 (s, 2H), 4.35 (t, J=2.3 Hz, 1H), 4.18
s, 5H), 3.87 (q, J=2.3 Hz, 2H), 3.09 (t, J=2.3 Hz, 1H), 2.94–2.86 (m,
Experimental Section
(
2
H), 1.71–1.63 (m, 2H), 1.42–1.22 (m, 4H), 1.35 ppm (s, 9H);
General methods
1
3
C NMR (CDCl , 298 K): d=172.08, 170.95, 155.95, 79.40, 78.85,
3
All synthesis reactions were carried out under air unless indicated
otherwise. N,N-Diisopropylethylamine, propargylamine, diethylami-
noethyl cellulose, adenosine 5’-triphosphate disodium salt, Azide-
fluor488, and N,N’-dicyclohexylcarbodiimide were obtained from
Sigma Aldrich and used as received. Dowex AG 50W-X8 was pur-
chased from Bio-Rad Laboratories (Ontario, Canada). H-Lys(Boc)-
OMe·HCl, hydroxybenzotriazole, and 1-ethyl-3-(3-dimethylamino-
propyl)carbodiimide were bought from AAPPTec LLC (KY, USA). Dry
dimethylformamide was purchased from Fisher Scientific. Dichloro-
74.87, 71.37, 70.60, 69.65, 68.41, 68.22, 53.34, 52.62, 40.02, 31.86,
29.37, 28.93, 28.31, 22.70 ppm; MS (ESI+): m/z calcd for
+
C
H
25
34FeN O
3
: 496.1899 [M+H ]; found: 496.1879.
4
Preparation of Fc-CO-Lys-NH2 (3): Neat TFA (4 mL) was used to
dissolve Fc-CO-Lys-Boc (720 mg, 1.44 mmol). After stirring the solu-
tion for one hour, dichloromethane (20 mL) was added to dilute
the solution before remove the solvent in vacuum. Three portions
of dichloromethane were added and evaporated to get rid of the
excess TFA. The residue was dissolved in dichloromethane (10 mL)
and TEA (5 mL) was added to convert the TFA salt to free amine
completely. After solvent removal, the mixture was used in the
next step without further purification.
methane was distilled by using CaH before use. Methanol was dis-
2
tilled from magnesium turnings with the presence of iodine. Ferro-
[
32]
[33]
cenecarboxylic acid, Fc-CO-Lys(OMe)-NHBoc (1), and adenosine
5
[9d]
’-[g-ferrocene] triphosphate (Fc-CO-C6-ATP) were prepared ac-
Preparation of Fc-CO-Lys-ATP (4): Adenosine 5’-triphosphate diso-
dium salt (100 mg, 0.18 mmol) was dissolved in 0.1m TEAB buffer
cording to the literature procedures assigned to each compound.
1
31
H and P NMR experiments were performed on a Bruker Advance
(
pH 7.5) (10 mL) and loaded on a column packed with a cation-ex-
change resin (AG 50W-X8), which has been pre-equilibrated with
.1m TEAB buffer. The desired fraction (monitored by UV light) was
5
00 MHz spectrometer. The initial geometry of Fc-CO-C6-ATP and
[34]
Fc-CO-Lys-ATP conjugates was energy-optimized by Gaussian.
0
The optimized co-substrate structures were superimposed onto
the binding site of the Src kinase (PBD 1y57) and CDK2/Cyclin A
kinase (PBD4eoo) and modeled by ArgusLab 4.0.1 (Mark A. Thomp-
com).
collected and evaporated in vacuum. The residue was co-evaporat-
ed with dry methanol (10 mL) for three times and dissolved in dry
DMF (1.8 mL) under argon. This ATP solution was further dried by
pre-activated molecular sieves over night. DCC (123 mg) was
added into the ATP solution and the mixture was stirred under Ar
for three hours at room temperature to form adenosine-5’-trimeta-
phosphate (ATMP). The ATMP solution was added to a mixture of
compound 3 (8 equiv) in dry MeOH (10 mL) and TEA (0.25 mL, pre-
dried by molecular sieves) under Ar. The mixture was stirred for
The Src peptide substrate, EGIYDVP, was obtained from BioBasic
Inc (Markham, Ontario). The CDK2 peptide substrate (HHASPRK),
the CDK2/cyclin A complex, and the Src kinase were purchased
from Cell Signaling (New England Biolabs Ltd., Pickering, Ontario).
The CK2a and the peptide substrate (RRRDDDSDDD) were pre-
pared in the laboratory of D. W. Litchfield (University of Western
Ontario).
one day, and poured into H O (20 mL). The solution was loaded on
2
a DEAE-cellulose column and washed with distilled H O to remove
2
excess ferrocene-amine. Then, a linear gradient of TEAB buffer
(0.1–0.5m) was carried out to give the desired fraction (yellow
band ꢀ0.3–0.4m TEAB), which was lyophilized to give a light
yellow powder. The product was further purified by HPLC (Varian
Serum enriched with polyclonal rabbit antiferrocene antibodies
(
Fc-Ab ) was produced at the YenZym Antibodies, LLC (CA, U.S.)
1
against the monosubstituted ferroceneamide-alkylamine and used
Chem. Eur. J. 2015, 21, 4988 – 4999
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim